Tijaria Polypipes Intrinsic Value
Tijaria Polypipes (TIJARIA) median intrinsic value is ₹16.83 from 1 valuation models (range ₹17–₹17), vs current price ₹6.73 — +150.1% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Tijaria Polypipes share price today.
TIJARIA Valuation Methods Summary — DCF, Graham Number & P/E
Tijaria Polypipes intrinsic value across 1 models vs current price ₹6.73 — upside/downside and value range per method. Browse TIJARIA complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Simple DCF (5Y) | dcf | ₹16.83 | ₹13.46 - ₹20.20 | +150.1% | CF Growth: 15.0%, Discount: 15% |
TIJARIA Intrinsic Value vs Market Price — All Valuation Models
Tijaria Polypipes fair value range ₹17–₹17 vs current market price ₹6.73 across 1 valuation models. Compare with Tijaria Polypipes value estimation to assess whether the stock is under or overvalued.
TIJARIA Intrinsic Value Analysis — Undervalued or Overvalued?
Tijaria Polypipes median intrinsic value ₹16.83, current price ₹6.73 — Trading Below Calculated Value by 150.1%, margin of safety 60.0%.
What is the intrinsic value of TIJARIA?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Tijaria Polypipes (TIJARIA) is ₹16.83 (median value). With the current market price of ₹6.73, this represents a +150.1% variance from our estimated fair value.
The valuation range spans from ₹16.83 to ₹16.83, indicating ₹16.83 - ₹16.83.
Is TIJARIA undervalued or overvalued?
Based on our multi-method analysis, Tijaria Polypipes (TIJARIA) appears to be trading below calculated value by approximately 150.1%.
TIJARIA Financial Health — Key Ratios vs Industry Benchmarks
Tijaria Polypipes financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.55 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -1.67 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | 15.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
TIJARIA Cash Flow Quality — Operating & Free Cash Flow
Tijaria Polypipes operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |